Hjem › Schizofreni › Georgia
Kliniske studier for Schizofreni i Georgia
29 studier for Schizofreni søker deltakere på steder i Georgia.
Byer i Georgia
Offisiell studietekst (engelsk)
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
- Vanda Investigational Site, Atlanta
- Vanda Investigational Site, Atlanta
- Vanda Investigational Site, Decatur
RekruttererFase 4
Alder 12 til 17 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT05648591A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
- Synexus Clinical Research US Inc, Atlanta
RekruttererFase 1
Alder 18 til 55 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07615426Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Atlanta Center for Medical Research, Atlanta
- Local Institution - 0070, Sandy Springs
- Local Institution - 0189, Savannah
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07686263Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- CenExeli Research LLC, Atlanta
- Atlanta Center for Medical Research, Atlanta
- CenExeli Research LLC 1, Savannah
RekruttererFase 3
Alder 5 til 17 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06229210NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Atlanta
- Neurocrine Clinical Site, Atlanta
- Neurocrine Clinical Site, Decatur
- og 1 flere
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07114874Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Neurocrine Clinical Site, Atlanta
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07227818A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Atlanta Center for Medical Research, Atlanta
- Salveo Integrative Health - Lawrenceville, Lawrenceville
- Denali Health Atlanta, LLC, Stone Mountain
RekruttererFase 3
Alder 5 til 17 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07424404A Study of Brenipatide in Adult Participants With Schizophrenia
- Atlanta Center for Medical Research, Atlanta
- Augusta University, Augusta
RekruttererFase 2
Alder 18 til 55 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07410507A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Augusta
RekruttererFase 4
Alder 18 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT07105111A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- CenExel iResearch, LLC, Decatur
RekruttererFase 1
Alder 18 til 55 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT0773449352-week Open Label Safety-Tolerability Study
- CenExel, Atlanta
- Accelerated Clinical Trial, Snellville
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07369154A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Atlanta Center for Medical Research, Atlanta
- Salveo Integrative Health - Lawrenceville, Lawrenceville
- Denali Health Atlanta, LLC, Stone Mountain
RekruttererFase 3
Alder 13 til 17 · Alle kjønn · Oppdatert 4. sep. 2026 · NCT07288567A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
- Atlanta Center for Medical Research, Atlanta
- CenExel iResearch, LLC, Decatur
RekruttererFase 1
Alder 18 til 55 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07061288A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Atlanta
- Clinical Site, Decatur
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 1. sep. 2026 · NCT07459647Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Emory University., Atlanta
- Local Institution - 0049, Austell
- Local Institution - 0044, Marietta
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 19. aug. 2026 · NCT07379827Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Alkermes Investigator Site, Decatur
RekruttererFase 3
Alder 10 til 17 · Alle kjønn · Oppdatert 14. aug. 2026 · NCT05303064Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
- Bioxcel Clinical Research Site, Decatur
RekruttererFase 1
Alder 10 til 17 · Alle kjønn · Oppdatert 11. aug. 2026 · NCT05025605Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
- CenExel iResearch, Decatur
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 29. jul. 2026 · NCT07467993Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
- Accelerated Clinical Trial, Snellville
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 27. jul. 2026 · NCT07363577A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Cenexel ACMR, Atlanta
- Cenexel iResearch Atlanta, Decatur
RekruttererFase 2
Alder 18 til 55 · Alle kjønn · Oppdatert 23. jun. 2026 · NCT07191483Anti-Inflammatory Challenge in Schizophrenia
- Grady Memorial Hospital, Atlanta
- Emory University Hospital, Atlanta
RekruttererFase 4
Alder 18 til 55 · Alle kjønn · Oppdatert 3. jun. 2026 · NCT05823532CLOZAPINE Response in Biotype-1
- University of Georgia, Athens
RekruttererFase 4
Alder 18 til 60 · Alle kjønn · Oppdatert 11. mai 2026 · NCT04580134Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
- Augusta University Research Institute, Inc., Augusta
RekruttererFase 4
Alder 18 til 65 · Alle kjønn · Oppdatert 4. mai 2026 · NCT05208190Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Georgia, Athens
RekruttererObservasjonsstudie
Alder 18 til 40 · Alle kjønn · Oppdatert 10. mar. 2026 · NCT06740383NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Atlanta
- Neurocrine Clinical Site, Decatur
- Neurocrine Clinical Site, Snellville
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 6. mar. 2026 · NCT06963034Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Atlanta
- Vanda Investigational Site, Peachtree Corners
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 12. jan. 2026 · NCT06961968Study of ALTO-101 in Patients With Schizophrenia
- Site 5064, Snellville
RekruttererFase 2
Alder 21 til 55 · Alle kjønn · Oppdatert 26. des. 2025 · NCT06502964Cognitive Training for Emotion Regulation in Psychotic Disorders
- University of Georgia, Athens
Rekrutterer
Alder 18 til 60 · Alle kjønn · Oppdatert 5. feb. 2025 · NCT04414215Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Atlanta
- Reviva site, Decatur
RekruttererFase 3Frivillige helsepersonell ønskes velkommen
Alder 18 til 65 · Alle kjønn · Oppdatert 19. des. 2024 · NCT05184335Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.